| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 14 |
| 1 | PACLITAXEL (AIBUMIN-BOUND) | 14 |
| 2 | BEVACIZUMAB | 10 |
| 3 | DENOSUMAB | 8 |
| 4 | EVEROLIMUS | 8 |
| 5 | FULVESTRANT | 8 |
| 6 | CAPECITABINE | 7 |
| 7 | CARBOPLATIN | 7 |
| 8 | EXEMESTANE | 7 |
| 9 | MACITENTAN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALETRECTINIB | 1 | 0.0092 |
| 1 | TISLELIZUMAB-JSGR | 1 | 0.0045 |
| 2 | MIGLITOL | 3 | 0.0031 |
| 3 | DOBUTAMINE | 5 | 0.0013 |
| 4 | NITRIC OXIDE | 6 | 0.0013 |
| 5 | ENTRECTINIB | 2 | 0.0012 |
| 6 | ILOPROST | 1 | 0.0011 |
| 7 | AVELUMAB | 2 | 0.0005 |
| 8 | NERATINIB | 1 | 0.0004 |
| 9 | SITAGLIPTIN PHOSPHATE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 3 | 0.0006 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 3 | Estrogen Receptor Antagonist [EPC] | 8 | 0.0002 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 5 | Microtubule Inhibitor [EPC] | 18 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 7 | 0.0001 |
| 7 | Aromatase Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 9 | 0.0001 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |